SlipstreamJobs tracks this role from the company's public career site. Apply directly on the employer's site.
Salary: USD 48,000 - 73,600 / annual
PathAI is transforming pathology through AI-powered diagnostics to accelerate drug development, improve diagnostic accuracy, and deliver life-saving therapies faster. We seek an Implementation Engineer to support our digital diagnostics customers, including anatomic pathology labs, academic medical centers, hospital systems, and clinical trial managers.
In this role, you will be the primary technical point of contact during customer implementation phases. You will build and maintain strong relationships with customers while providing hands-on technical implementation support, coordinating with customer IT teams and internal development teams as needed. You will manage all implementation project tasks, including scheduling, risk and issue resolution, and regular customer communication. You will also serve as an application expert and escalation point for our support team, including participation in an on-call rotation.
The role requires fluency in English (spoken and written), with Portuguese or French preferred. Travel of less than 20% is expected.
PathAI's digital diagnostics portfolio includes commercially deployed AI products, a clinical trials platform, and AISight, our Digital Pathology Image Management System. We emphasize cultural fit, a hunger to learn our business and customers, and the drive to advance in this rapidly evolving industry.
REQUIREMENTS:
- 2–5 years of experience in client-facing SaaS implementation roles
- Strong analytical skills and operating rigor
- Demonstrated ability to handle difficult customers or situations and resolve them effectively
- Strong understanding of business and products; ability to research and self-start in new areas
- Familiarity with HL7 interface implementation
- Preferred: hands-on experience with market-leading laboratory information systems (Epic Beaker, Novopath, Cerner Millennium, etc.)
- Willingness to travel less than 20%
